28.01.2014 Views

Pesticide residues in food — 2007: Toxicological ... - ipcs inchem

Pesticide residues in food — 2007: Toxicological ... - ipcs inchem

Pesticide residues in food — 2007: Toxicological ... - ipcs inchem

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

57<br />

Table 6. Selected f<strong>in</strong>d<strong>in</strong>gs from a study <strong>in</strong> rats fed diets conta<strong>in</strong><strong>in</strong>g atraz<strong>in</strong>e for 104 weeks<br />

F<strong>in</strong>d<strong>in</strong>g<br />

Dietary concentration (ppm)<br />

0 70 400<br />

Unscheduled deaths, weeks 1–55 (No. of rats) 0 0 5<br />

Unscheduled deaths, weeks 1–104 (No. of rats) 5 6 8<br />

Palpable mammary masses, a weeks 1–54 (No. of rats) 6 3 14<br />

Palpable mammary masses, a weeks 55–104 (No. of rats) 10 13 8<br />

Fluid-filled uterus, weeks 1–54 (No. of rats/No. exam<strong>in</strong>ed histopathologically) 4/40 10/40 14/40<br />

Fluid-filled uterus, weeks 1–104 (No. of rats/No. exam<strong>in</strong>ed histopathologically) 5/70 15/70 15/70<br />

Mammary galactocoele, weeks 1–54 (No. of rats/No. exam<strong>in</strong>ed<br />

histopathologically)<br />

Mammary galactocoele, weeks 1–104 (No. of rats/No. exam<strong>in</strong>ed<br />

histopathologically)<br />

Mammary fibroadenoma, weeks 1–54 (No. of rats/No. exam<strong>in</strong>ed<br />

histopathologically)<br />

6/39 9/38 20/41<br />

29/69 30/67 41/69<br />

1/39 0/38 4/41<br />

Mammary carc<strong>in</strong>oma, weeks 1–54 (No. of rats/No. exam<strong>in</strong>ed histopathologically) 0/39 1/38 6/41<br />

Mammary fibroadenoma, weeks 1–104 (No. of animals) 8/69 12/67 13/69<br />

Mammary carc<strong>in</strong>oma, weeks 1–104 (No. of rats/No. exam<strong>in</strong>ed histopathologically) 9/69 4/67 11/69<br />

Pituitary adenoma, weeks 1–54 (No. of rats/No. exam<strong>in</strong>ed histopathologically) 2/39 2/40 8/43<br />

Pituitary adenoma, weeks 1–104 (No. of rats/No. exam<strong>in</strong>ed histopathologically) 22/68 16/69 20/69<br />

From Thakur (1991a)<br />

a<br />

Histologically confirmed as tumours.<br />

The NOAEL was 70 ppm, equivalent to 3.5 mg/kg bw per day, on the basis of <strong>in</strong>creased mortality,<br />

decreased body-weight ga<strong>in</strong> and an earlier onset of mammary and pituitary tumours at 400 ppm<br />

(Thakur, 1991a).<br />

From the rats <strong>in</strong> the supplementary study of carc<strong>in</strong>ogenicity described above (Thakur, 1991a),<br />

data on estrous cycles, vag<strong>in</strong>al cytology and selected serum hormone levels were also collected from<br />

rats killed at 1, 3, 9, 12, 15, 18 and 24 months. Results were evaluated as a function of treatment and<br />

as a function of treatment over time.<br />

Normal age-related changes noted <strong>in</strong> rats <strong>in</strong> the control group <strong>in</strong>cluded an <strong>in</strong>crease <strong>in</strong> the number<br />

of days when high density cornified cells were evident <strong>in</strong> vag<strong>in</strong>al smears dur<strong>in</strong>g 12 months, with a<br />

decrease <strong>in</strong> this <strong>in</strong>dex between 12 and 18 months. Beg<strong>in</strong>n<strong>in</strong>g at approximately age 1 year, episodes of<br />

persistent vag<strong>in</strong>al estrus occurred, result<strong>in</strong>g <strong>in</strong> an <strong>in</strong>crease <strong>in</strong> percentage of total days <strong>in</strong> estrus at the<br />

expense of days <strong>in</strong> diestrus. Serum estradiol (E2) concentrations <strong>in</strong>creased between 1 and 9 months<br />

of the study, followed by decreased levels between months 9 and 18.<br />

Atraz<strong>in</strong>e-treated rats had a dose-related <strong>in</strong>crease <strong>in</strong> percentage days <strong>in</strong> estrus at each <strong>in</strong>terval<br />

between 9 and 18 months. Compared with rats <strong>in</strong> the control group, the cornified cell <strong>in</strong>dex <strong>in</strong> treated<br />

rats showed a similar <strong>in</strong>crease to that <strong>in</strong> controls until 12 months, but a slower decl<strong>in</strong>e between 12 and<br />

18 months. Episodes of persistent vag<strong>in</strong>al estrus were observed earlier <strong>in</strong> treated groups. Although<br />

serum concentrations of E2 <strong>in</strong>creased <strong>in</strong> the control group and <strong>in</strong> the groups treated with atraz<strong>in</strong>e,<br />

the magnitude of the <strong>in</strong>crease was greater than that <strong>in</strong> the control group between 1 and 9 months <strong>in</strong><br />

the group at 400 ppm. Overall, treatment with atraz<strong>in</strong>e accelerated the development of typical agerelated<br />

changes <strong>in</strong> female Sprague-Dawley rats. As a result, rats treated with atraz<strong>in</strong>e were exposed<br />

to persistent endogenous estrogens for longer periods of time (Eldridge et al., 1993a).<br />

ATRAZINE 37–138 JMPR <strong>2007</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!